Sean Deering1, Lin Liu1,2, Tania Zamora1, Joanne Hamilton3, Carl Stepnowsky1,4. 1. Health Services Research and Development, VA San Diego Healthcare System, La Jolla, California. 2. Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California. 3. Advanced Neurobehavioral Health, Poway, California. 4. Department of Medicine, University of California San Diego, La Jolla, California.
Abstract
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is a widespread condition that adversely affects physical health and cognitive functioning. The prevailing treatment for OSA is continuous positive airway pressure (CPAP), but therapeutic benefits are dependent on consistent use. Our goal was to investigate the relationship between CPAP adherence and measures of sustained attention in patients with OSA. Our hypothesis was that the Psychomotor Vigilance Task (PVT) would be sensitive to attention-related improvements resulting from CPAP use. METHODS: This study was a secondary analysis of a larger clinical trial. Treatment adherence was determined from CPAP use data. Validated sleep-related questionnaires and a sustained-attention and alertness test (PVT) were administered to participants at baseline and at the 6-month time point. RESULTS: Over a 6-month time period, the average CPAP adherence was 3.32 h/night (standard deviation [SD] = 2.53), average improvement in PVT minor lapses was -4.77 (SD = 13.2), and average improvement in PVT reaction time was -73.1 milliseconds (standard deviation = 211). Multiple linear regression analysis showed that higher CPAP adherence was significantly associated with a greater reduction in minor lapses in attention after 6 months of continuous treatment with CPAP therapy (β = -0.72, standard error = 0.34, P = .037). CONCLUSIONS: The results of this study showed that higher levels of CPAP adherence were associated with significant improvements in vigilance. Because the PVT is a performance-based measure that is not influenced by prior learning and is not subjective, it may be an important supplement to patient self-reported assessments. CLINICAL TRIAL REGISTRATION: Name: Effect of Self-Management on Improving Sleep Apnea Outcomes, URL: https://clinicaltrials.gov/ct2/show/NCT00310310, Identifier: NCT00310310.
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is a widespread condition that adversely affects physical health and cognitive functioning. The prevailing treatment for OSA is continuous positive airway pressure (CPAP), but therapeutic benefits are dependent on consistent use. Our goal was to investigate the relationship between CPAP adherence and measures of sustained attention in patients with OSA. Our hypothesis was that the Psychomotor Vigilance Task (PVT) would be sensitive to attention-related improvements resulting from CPAP use. METHODS: This study was a secondary analysis of a larger clinical trial. Treatment adherence was determined from CPAP use data. Validated sleep-related questionnaires and a sustained-attention and alertness test (PVT) were administered to participants at baseline and at the 6-month time point. RESULTS: Over a 6-month time period, the average CPAP adherence was 3.32 h/night (standard deviation [SD] = 2.53), average improvement in PVT minor lapses was -4.77 (SD = 13.2), and average improvement in PVT reaction time was -73.1 milliseconds (standard deviation = 211). Multiple linear regression analysis showed that higher CPAP adherence was significantly associated with a greater reduction in minor lapses in attention after 6 months of continuous treatment with CPAP therapy (β = -0.72, standard error = 0.34, P = .037). CONCLUSIONS: The results of this study showed that higher levels of CPAP adherence were associated with significant improvements in vigilance. Because the PVT is a performance-based measure that is not influenced by prior learning and is not subjective, it may be an important supplement to patient self-reported assessments. CLINICAL TRIAL REGISTRATION: Name: Effect of Self-Management on Improving Sleep Apnea Outcomes, URL: https://clinicaltrials.gov/ct2/show/NCT00310310, Identifier: NCT00310310.
Authors: Vincent Mysliwiec; Vincent F Capaldi; Jessica Gill; Tristin Baxter; Brian M O'Reilly; Panagiotis Matsangas; Bernard J Roth Journal: Mil Med Date: 2015-04 Impact factor: 1.437
Authors: Ina Djonlagic; Mengshuang Guo; Paul Matteis; Andrea Carusona; Robert Stickgold; Atul Malhotra Journal: Sleep Med Date: 2015-02-27 Impact factor: 3.492
Authors: Angela L D'Rozario; Camilla M Hoyos; Keith K H Wong; Gunnar Unger; Jong Won Kim; Andrew Vakulin; Chien-Hui Kao; Sharon L Naismith; Delwyn J Bartlett; Ronald R Grunstein Journal: Sleep Date: 2022-06-13 Impact factor: 6.313